Highlights

Highlights

  • 19.08.2026 – 12:39

    Flo Optics

    Flo Optics: flo Optics Appoints Marc Syz as New Director to Board of Directors to Support Global Growth and Swiss Expansion

    flo Optics Appoints Marc Syz as New Director to Board of Directors to Support Global Growth and Swiss Expansion

    Brugg, Switzerland (ots) - flo Optics, a pioneer in digitalizing optical lens coating and manufacturing, is proud to announce the appointment of Marc Syz as a new Director to its Board. This strategic addition reinforces the company's expanding Swiss operations, accelerates its transition into its intensive growth phase, and underscores flo Optics' deep commitment to expanding leadership diversity and broadening its international perspective. With its Swiss subsidiary operating out of Brugg in the Zurich area, the company is transforming the traditional ophthalmic industry through its ...

Neueste Storys

Filtern
  • 12.01.2015 – 15:02

    Mundoro Capital Inc.

    Mundoro Extends Copper Mineralization With Drill Program at Zeleznik Property, Serbia

    Vancouver, British Columbia (ots/PRNewswire) - Mundoro Capital Inc. ("Mundoro" or the "Company") is pleased to announce the drilling results from its 100% owned Zeleznik license, located at the northern portion of the Timok Magmatic Complex in northeastern Serbia. The Zeleznik license covers 60kmsquared and is located 1.8km directly north of, and adjacent to, the ...

  • 12.01.2015 – 08:32

    Debiopharm International SA

    Debiopharm Group(TM) Regains Full Rights to Alisporivir Program

    Lausanne, Switzerland (ots/PRNewswire) - - Novartis returns Alisporivir (DEB025) to Debiopharm Group(TM) including all rights for HCV and other indications - Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company, today announced that it has updated its arrangement with Novartis to regain full rights to Alisporivir (DEB025) currently completing two Phase 2 studies of interferon-free treatment in ...

  • 10.01.2015 – 00:13

    Hikma Pharmaceuticals PLC

    Hikma to Launch Colchicine 0.6mg Capsules

    London (ots/PRNewswire) - Hikma Pharmaceuticals PLC ("Hikma") , the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. ("Takeda") has been unsuccessful in appealing the decision by the United States District Court for the District of Delaware to deny Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine 0.6mg capsules for the ...

  • 09.01.2015 – 11:45

    XL Group Plc

    XL Group Plc Announces Acquisition of Catlin Group Limited

    Dublin, Ireland (ots/PRNewswire) - - Expected to Create a Leader in Global Specialty Insurance and Reinsurance Markets - Expected to Create Double Digit EPS and Meaningful ROE Accretion XL Group plc today announced that it has entered into an agreement under which XL will offer to acquire all of the capital stock of Catlin Group Limited to form a combined business which is expected to have a leading presence in the global ...